Global Anainterleukin Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

According to our (Global Info Research) latest study, the global Anainterleukin market size was valued at US$ 5618 million in 2025 and is forecast to a readjusted size of US$ 15626 million by 2032 with a CAGR of 15.9% during review period.
Anainterleukin, also known as Anakinra, is a recombinant non-glycosylated human interleukin‑1 receptor antagonist (IL-1Ra). It is prepared by genetic engineering technology and expressed in Escherichia coli, belonging to immunomodulatory biological drugs. It specifically competes to bind to interleukin‑1 receptors (IL-1RI) on human cell surfaces, blocks the binding of interleukin‑1α (IL-1α) and interleukin‑1β (IL-1β) to their receptors, inhibits the activation of inflammatory signaling pathways, and thereby alleviates excessive inflammatory responses in the body. With a definite mechanism of action and low immunogenicity, it is clinically applied mainly in the treatment of autoimmune and inflammatory diseases, providing a safe and effective immunomodulatory regimen for such conditions.In 2025, global Anainterleukin (anakinra) production reached approximately 9.8 million vials.
Anainterleukin (Anakinra) is a classic immunomodulatory drug targeting the IL-1 pathway, with its global market showing steady expansion. The core driving force stems from the growing demand for the treatment of autoimmune and rare inflammatory diseases. Its indications have gradually expanded from traditional rheumatoid arthritis to rare disease fields such as Cryopyrin-Associated Periodic Syndromes (CAPS) and Systemic Juvenile Idiopathic Arthritis (sJIA), gaining increasing clinical recognition. In terms of market pattern, original research enterprises dominate the market by virtue of first-mover advantages and patent protection. Meanwhile, with the advancement of biosimilar research and development as well as the expansion of medical insurance coverage, market competition has become increasingly active and drug accessibility has been continuously improved. At the technical level, the research and development of improved formulations such as long-acting preparations and optimized administration devices focuses on improving patients’ medication compliance and treatment convenience, becoming a key development direction in the industry. Currently, the growth of the global market benefits from the rising diagnosis rate of inflammatory diseases, increased penetration of targeted therapy and in-depth research on immunotherapy. In the future, with further expansion of indications, intensified competition from generic drugs and the launch of innovative dosage forms, the market will maintain structural growth and evolve toward a more inclusive and specialized treatment ecosystem.
This report is a detailed and comprehensive analysis for global Anainterleukin market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Anainterleukin market size and forecasts, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
Global Anainterleukin market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
Global Anainterleukin market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
Global Anainterleukin market shares of main players, shipments in revenue ($ Million), sales quantity (Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Anainterleukin
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Anainterleukin market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Hospira Zagreb d.o.o., etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Anainterleukin market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
00 mg (0.67 mL) per vial
150 mg (1.0 mL) per vial
Market segment by Dosage Form
Sterile Powder for Injection
Injection Solution
Market segment by Route of Administration
Subcutaneous Injection
Intravenous Infusion
Market segment by Sales Channel
Hospital
Retail
Online
Market segment by Application
Rheumatoid Arthritis
Systemic Juvenile Idiopathic Arthritis
Cryopyrin-Associated Periodic Syndromes
Others
Major players covered
Hospira Zagreb d.o.o.
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Anainterleukin product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Anainterleukin, with price, sales quantity, revenue, and global market share of Anainterleukin from 2021 to 2026.
Chapter 3, the Anainterleukin competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Anainterleukin breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Anainterleukin market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Anainterleukin.
Chapter 14 and 15, to describe Anainterleukin sales channel, distributors, customers, research findings and conclusion.